Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Exp Clin Psychopharmacol. 2020 Jul 13;29(6):689–695. doi: 10.1037/pha0000409

Table 1.

Sample Characteristics.

Variablea Males (n = 20) Females (n = 17) Test for Difference

Age 27.70 (5.86) 27.06 (4.39) t(35) = 0.37, p = 0.71
AUDITb 12.90 (3.88) 13.12 (6.03) t(35) = −0.13, p = 0.90
ADSc 11.55 (4.72) 9.88 (4.83) t(35) = 1.06, p = 0.30
PACSd 8.15 (3.88) 9.41 (5.40) t(35) = −0.82, p = 0.42
CUDITe 4.45 (2.68) 4.18 (3.09) t(35) = 0.29, p = 0.77
Cannabis use daysf 1.70 (1.42) 3.24 (3.03) t(21.87) = −1.92, p = 0.07
Drinking daysf 19.90 (6.22) 16.06 (5.90) t(35) = 1.92, p = 0.06
DPDDg, f 5.44 (1.87) 4.38 (1.63) t(35) = 1.81, p = 0.08
Alcohol and cannabis co-use daysf 1.30 (1.42) 1.59 (1.62) t(35) = −0.58, p = 0.57
Tobacco use daysf 7.95 (12.38) 4.47 (9.23) t(35) = 0.95, p = 0.35
BDI-IIh 6.75 (6.62) 11.18 (9.74) t(35) = 1.64, p = 0.11
BAIi 4.55 (4.30) 8.29 (5.80) t(35) = −2.25, p < 0.05*
a

Standard deviations appear within parentheses for continuous variables.

b

Alcohol Use Disorders Identification Test (AUDIT).

c

Alcohol Dependence Scale (ADS).

d

Penn Alcohol Craving Scale (PACS).

e

Cannabis Use Disorders Identification Test – Revised (CUDIT).

f

Assessed by the Timeline Follow Back (TLFB) interview for the past 30 days.

g

Drinks per drinking day (DPDD).

h

Beck Depression Inventory – II (BDI-II).

i

Beck Anxiety Inventory (BAI).

*

Single asterisks denote group differences.